Table of Contents Author Guidelines Submit a Manuscript
Journal of Cancer Epidemiology
Volume 2016 (2016), Article ID 2138259, 9 pages
http://dx.doi.org/10.1155/2016/2138259
Research Article

Risk of Cancer among Commercially Insured HIV-Infected Adults on Antiretroviral Therapy

1University of Arkansas for Medical Sciences, Little Rock, AR, USA
2Duke University, Durham, NC, USA
3University of Washington, Seattle, WA, USA
4Memorial Sloan-Kettering Cancer Center, New York, NY, USA
5University of California, San Francisco, San Francisco, CA, USA
6Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY, USA
7AIDS Malignancy Consortium, New York, NY, USA
8Johns Hopkins University, Baltimore, MD, USA
9University of California, Los Angeles, Los Angeles, CA, USA

Received 6 June 2016; Revised 27 September 2016; Accepted 11 October 2016

Academic Editor: Yun-Ling Zheng

Copyright © 2016 Jeannette Y. Lee et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Samji, A. Cescon, R. S. Hogg et al., “Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada,” PLoS ONE, vol. 8, no. 12, Article ID e81355, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. M. S. Shiels, S. R. Cole, G. D. Kirk, and C. Poole, “A meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals,” Journal of Acquired Immune Deficiency Syndromes, vol. 52, no. 5, pp. 611–622, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. P. Patel, D. L. Hanson, P. S. Sullivan et al., “Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992–2003,” Annals of Internal Medicine, vol. 148, no. 10, pp. 728–736, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. M. S. Shiels, R. M. Pfeiffer, H. I. Hall et al., “Proportions of Kaposi sarcoma, selected non-Hodgkin lymphomas, and cervical cancer in the United States occurring in persons with AIDS, 1980–2007,” The Journal of the American Medical Association, vol. 305, no. 14, pp. 1450–1459, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. E. A. Engels, R. J. Biggar, H. I. Hall et al., “Cancer risk in people infected with human immunodeficiency virus in the United States,” International Journal of Cancer, vol. 123, no. 1, pp. 187–194, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. E. C. Seaberg, D. Wiley, O. Martínez-Maza et al., “Cancer incidence in the multicenter aids cohort study before and during the HAART era: 1984 to 2007,” Cancer, vol. 116, no. 23, pp. 5507–5516, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Hleyhel, A. Belot, A. M. Bouvier et al., “Risk of AIDS-defining cancers among HIV-1-infected patients in france between 1992 and 2009: results from the FHDH-ANRS CO4 cohort,” Clinical Infectious Diseases, vol. 57, no. 11, pp. 1638–1647, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Franceschi, M. Lise, G. M. Clifford et al., “Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study,” British Journal of Cancer, vol. 103, no. 3, pp. 416–422, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. C. Piketty, H. Selinger-Leneman, A.-M. Bouvier et al., “Incidence of HIV-related anal cancer remains increased despite long-term combined antiretroviral treatment: results from the French hospital database on HIV,” Journal of Clinical Oncology, vol. 30, no. 35, pp. 4360–4366, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. C. Chao, W. A. Leyden, L. Xu et al., “Exposure to antiretroviral therapy and risk of cancer in HIV-infected persons,” AIDS, vol. 26, no. 17, pp. 2223–2231, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. D. Gotti, M. Danesi, A. Calabresi et al., “Clinical characteristics, incidence, and risk factors of HIV-related Hodgkin lymphoma in the era of combination antiretroviral therapy,” AIDS Patient Care and STDs, vol. 27, no. 5, pp. 259–265, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. J. J. Goedert and M. Bower, “Impact of highly effective antiretroviral therapy on the risk for Hodgkin lymphoma among people with human immunodeficiency virus infection,” Current Opinion in Oncology, vol. 24, no. 5, pp. 531–536, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. A. P. Wilper, S. Woolhandler, K. E. Lasser, D. McCormick, D. H. Bor, and D. U. Himmelstein, “Health insurance and mortality in US adults,” American Journal of Public Health, vol. 99, no. 12, pp. 2289–2295, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. “Cancer screening—United States, 2010,” MMWR Morbidity and Mortality Weekly Report, vol. 61, no. 3, pp. 41–45, 2010.
  15. T. H. Laz, M. Rahman, and A. B. Berenson, “Human papillomavirus vaccine uptake among 18- to 26-year-old women in the United States: National Health Interview Survey, 2010,” Cancer, vol. 119, no. 7, pp. 1386–1392, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. R. A. Cohen and M. E. Martinez, Health Insurance Coverage: Early Release of Estimates from the National Health Interview Survey, January–March 2013, NCfH Statistics, Washington, DC, USA, 2013.
  17. J. M. Blair, J. L. Fagan, E. L. Frazier et al., “Behavioral and clinical characteristics of persons receiving medical care for HIV infection-medical monitoring project, United States, 2009,” MMWR Surveillance Summaries, vol. 63, supplement 5, pp. 1–28, 2014. View at Google Scholar · View at Scopus
  18. G. Paz-Bailey, H. Pham, A. M. Oster et al., “Engagement in HIV care among HIV-positive men who have sex with men from 21 cities in the United States,” AIDS and Behavior, vol. 18, supplement 3, pp. S348–S358, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. B. R. Yehia, J. A. Fleishman, A. L. Agwu, J. P. Metlay, S. A. Berry, and K. A. Gebo, “Health insurance coverage for persons in HIV care, 2006–2012,” Journal of Acquired Immune Deficiency Syndromes, vol. 67, no. 1, pp. 102–106, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. G. Schneider, T. Juday, C. Wentworth III, S. Lanes, T. Hebden, and D. Seekins, “Impact of health care payer type on HIV stage of illness at time of initiation of antiretroviral therapy in the USA,” AIDS Care-Psychological and Socio-Medical Aspects of AIDS/HIV, vol. 25, no. 11, pp. 1470–1476, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. L. Traeger, C. O'Cleirigh, M. R. Skeer, K. H. Mayer, and S. A. Safren, “Risk factors for missed HIV primary care visits among men who have sex with men,” Journal of Behavioral Medicine, vol. 35, no. 5, pp. 548–556, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Calabresi, A. Ferraresi, A. Festa et al., “Incidence of AIDS-defining cancers and virus-related and non-virus-related non-AIDS-defining cancers among HIV-infected patients compared with the general population in a large health district of northern Italy, 1999–2009,” HIV Medicine, vol. 14, no. 8, pp. 481–490, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. E. L. Yanik, K. Tamburro, J. J. Eron, B. Damania, S. Napravnik, and D. P. Dittmer, “Recent cancer incidence trends in an observational clinical cohort of HIV-infected patients in the US, 2000 to 2011,” Infectious Agents and Cancer, vol. 8, no. 1, article 18, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. K. Petoumenos, M. T. van Leuwen, C. M. Vajdic et al., “Cancer, immunodeficiency and antiretroviral treatment: results from the Australian HIV Observational Database (AHOD),” HIV Medicine, vol. 14, no. 2, pp. 77–84, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. C. de Martel, M. S. Shiels, S. Franceschi et al., “Cancers attributable to infections among adults with HIV in the United States,” AIDS, vol. 29, no. 16, pp. 2173–2181, 2015. View at Publisher · View at Google Scholar
  26. H. A. Robbins, R. M. Pfeiffer, M. S. Shiels, J. Li, H. I. Hall, and E. A. Engels, “Excess cancers among HIV-infected people in the United States,” Journal of the National Cancer Institute, vol. 107, no. 4, 2015. View at Publisher · View at Google Scholar · View at Scopus
  27. H. A. Robbins, M. S. Shiels, R. M. Pfeiffer, and E. A. Engels, “Epidemiologic contributions to recent cancer trends among HIV-infected people in the United States,” AIDS, vol. 28, no. 6, pp. 881–890, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. E. P. Simard, R. M. Pfeiffer, and E. A. Engels, “Cumulative incidence of cancer among individuals with acquired immunodeficiency syndrome in the United States,” Cancer, vol. 117, no. 5, pp. 1089–1096, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. M. J. Silverberg, C. Chao, W. A. Leyden et al., “HIV infection, immunodeficiency, viral replication, and the risk of cancer,” Cancer Epidemiology Biomarkers and Prevention, vol. 20, no. 12, pp. 2551–2559, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Guiguet, F. Boue, J. Cadranel, J. M. Lang, E. Rosenthal, and D. Costagliola, “Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study,” The Lancet Oncology, vol. 10, no. 12, pp. 1152–1159, 2009. View at Publisher · View at Google Scholar
  31. E. A. Engels, J. O. Atkinson, B. I. Graubard et al., “Risk factors for human herpesvirus 8 infection among adults in the United States and evidence for sexual transmission,” Journal of Infectious Diseases, vol. 196, no. 2, pp. 199–207, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. E. A. Engels, “Human immunodeficiency virus infection, aging, and cancer,” Journal of Clinical Epidemiology, vol. 54, no. 12, supplement 1, pp. S29–S34, 2001. View at Publisher · View at Google Scholar · View at Scopus
  33. R. J. Biggar, E. S. Jaffe, J. J. Goedert, A. Chaturvedi, R. Pfeiffer, and E. A. Engels, “Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS,” Blood, vol. 108, no. 12, pp. 3786–3791, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. J. Bohlius, K. Schmidlin, F. Boue et al., “HIV-1-related Hodgkin lymphoma in the era of combination antiretroviral therapy: incidence and evolution of CD4+ T-cell lymphocytes,” Blood, vol. 117, no. 23, pp. 6100–6108, 2011. View at Publisher · View at Google Scholar
  35. R. K. Thomas, D. Re, T. Zander, J. Wolf, and V. Diehl, “Epidemiology and etiology of Hodgkin's lymphoma,” Annals of Oncology, vol. 13, supplement 4, pp. 147–152, 2002. View at Publisher · View at Google Scholar · View at Scopus
  36. E. Lanoy, P. S. Rosenberg, F. Fily et al., “HIV-associated Hodgkin lymphoma during the first months on combination antiretroviral therapy,” Blood, vol. 118, no. 1, pp. 44–49, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. G. M. Clifford, M. Rickenbach, M. Lise et al., “Hodgkin lymphoma in the Swiss HIV Cohort Study,” Blood, vol. 113, no. 23, pp. 5737–5742, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. M. J. Silverberg, C. Chao, W. A. Leyden et al., “HIV infection and the risk of cancers with and without a known infectious cause,” AIDS, vol. 23, no. 17, pp. 2337–2345, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. M. J. Silverberg, B. Lau, A. C. Justice et al., “Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North America,” Clinical Infectious Diseases, vol. 54, no. 7, pp. 1026–1034, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. R. J. Bedimo, K. A. McGinnis, M. Dunlap, M. C. Rodriguez-Barradas, and A. C. Justice, “Incidence of non-AIDS-defining malignancies in HIV-infected versus noninfected patients in the HAART era: impact of immunosuppression,” Journal of Acquired Immune Deficiency Syndromes, vol. 52, no. 2, pp. 203–208, 2009. View at Publisher · View at Google Scholar · View at Scopus
  41. M. J. Silverberg and D. I. Abrams, “Do antiretrovirals reduce the risk of non-AIDS-defining malignancies?” Current Opinion in HIV and AIDS, vol. 4, no. 1, pp. 42–51, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. E. Y. Chiao, C. M. Hartman, H. B. El-Serag, and T. P. Giordano, “The impact of HIV viral control on the incidence of HIV-associated anal cancer,” Journal of Acquired Immune Deficiency Syndromes, vol. 63, no. 5, pp. 631–638, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. C. Sadlier, D. Rowley, D. Morley et al., “Prevalence of human papillomavirus in men who have sex with men in the era of an effective vaccine; a call to act,” HIV Medicine, vol. 15, no. 8, pp. 499–504, 2014. View at Publisher · View at Google Scholar · View at Scopus
  44. C. E. Introcaso, E. F. Dunne, S. Hariri, G. Panicker, E. R. Unger, and L. E. Markowitz, “Prevaccine era human papillomavirus types 6, 11, 16 and 18 seropositivity in the USA, National Health and Nutrition Examination Surveys, 2003–2006,” Sexually Transmitted Infections, vol. 90, no. 6, pp. 505–508, 2014. View at Publisher · View at Google Scholar · View at Scopus
  45. P. V. Chin-Hong, E. Vittinghoff, R. D. Cranston et al., “Age-specific prevalence of anal human papillomavirus infection in HIV-negative sexually active men who have sex with men: the EXPLORE study,” Journal of Infectious Diseases, vol. 190, no. 12, pp. 2070–2076, 2004. View at Publisher · View at Google Scholar · View at Scopus
  46. A. L. Hernandez, J. T. Efird, E. A. Holly, J. M. Berry, N. Jay, and J. M. Palefsky, “Risk factors for anal human papillomavirus infection type 16 among HIV-positive men who have sex with men in San Francisco,” Journal of Acquired Immune Deficiency Syndromes, vol. 63, no. 4, pp. 532–539, 2013. View at Publisher · View at Google Scholar · View at Scopus
  47. S. A. Brunsberg, B. R. S. Rosser, and D. Smolenski, “HIV sexual risk behavior and health insurance coverage in men who have sex with men,” Sexuality Research and Social Policy, vol. 9, no. 2, pp. 125–131, 2012. View at Publisher · View at Google Scholar · View at Scopus
  48. T. A. Winston, S. F. P. Man, M. Hull, J. S. Montaner, and D. D. Sin, “Epidemic of lung cancer in patients with HIV infection,” Chest, vol. 143, no. 2, pp. 305–314, 2013. View at Publisher · View at Google Scholar · View at Scopus
  49. G. D. Kirk, C. Merlo, P. O'Driscoll et al., “HIV infection is associated with an increased risk for lung cancer, independent of smoking,” Clinical Infectious Diseases, vol. 45, no. 1, pp. 103–110, 2007. View at Publisher · View at Google Scholar · View at Scopus
  50. M. S. Shiels, S. R. Cole, S. H. Mehta, and G. D. Kirk, “Lung cancer incidence and mortality among HIV-infected and HIV-uninfected injection drug users,” Journal of Acquired Immune Deficiency Syndromes, vol. 55, no. 4, pp. 510–515, 2010. View at Publisher · View at Google Scholar · View at Scopus
  51. D. J. McKirnan, S. N. Du Bois, L. M. Alvy, and K. Jones, “Health care access and health behaviors among men who have sex with men: the cost of health disparities,” Health Education and Behavior, vol. 40, no. 1, pp. 32–41, 2013. View at Publisher · View at Google Scholar · View at Scopus
  52. A. Jamal, I. T. Agaku, E. O'Connor, B. A. King, J. B. Kenemer, and L. Neff, “Current cigarette smoking among adults—United States, 2005–2013,” Morbidity and Mortality Weekly Report (MMWR), vol. 63, no. 47, pp. 1108–1112, 2014. View at Google Scholar
  53. E. A. Engels, M. V. Brock, J. Chen, C. M. Hooker, M. Gillison, and R. D. Moore, “Elevated incidence of lung cancer among HIV-infected individuals,” Journal of Clinical Oncology, vol. 24, no. 9, pp. 1383–1388, 2006. View at Publisher · View at Google Scholar · View at Scopus
  54. G. M. Clifford, M. Lise, S. Franceschi et al., “Lung cancer in the Swiss HIV Cohort Study: role of smoking, immunodeficiency and pulmonary infection,” British Journal of Cancer, vol. 106, no. 3, pp. 447–452, 2012. View at Publisher · View at Google Scholar · View at Scopus
  55. M. S. Shiels, J. J. Goedert, R. D. Moore, E. A. Platz, and E. A. Engels, “Reduced risk of prostate cancer in U.S. Men with AIDS,” Cancer Epidemiology, Biomarkers & Prevention, vol. 19, no. 11, pp. 2910–2915, 2010. View at Google Scholar
  56. J. L. Marcus, C. R. Chao, W. A. Leyden et al., “Prostate cancer incidence and prostate-specific antigen testing among HIV-positive and HIV-negative men,” Journal of Acquired Immune Deficiency Syndromes, vol. 66, no. 5, pp. 495–502, 2014. View at Publisher · View at Google Scholar · View at Scopus
  57. G. Suneja, C. C. Lin, E. P. Simard, X. Han, E. A. Engels, and A. Jemal, “Disparities in cancer treatment among patients infected with the human immunodeficiency virus,” Cancer, vol. 122, no. 15, pp. 2399–2407, 2016. View at Publisher · View at Google Scholar
  58. G. Suneja, M. S. Shiels, R. Angulo et al., “Cancer treatment disparities in HIV-infected individuals in the United States,” Journal of Clinical Oncology, vol. 32, no. 22, pp. 2344–2350, 2014. View at Publisher · View at Google Scholar · View at Scopus
  59. G. Suneja, M. S. Shiels, S. K. Melville, M. A. Williams, R. Rengan, and E. A. Engels, “Disparities in the treatment and outcomes of lung cancer among HIV-infected individuals,” AIDS, vol. 27, no. 3, pp. 459–468, 2013. View at Publisher · View at Google Scholar · View at Scopus